Current Oncology (Jul 2023)

Radiotherapy in Uveal Melanoma: A Review of Ocular Complications

  • Lamprini Banou,
  • Zoi Tsani,
  • Konstantinos Arvanitogiannis,
  • Maria Pavlaki,
  • Anna Dastiridou,
  • Sofia Androudi

DOI
https://doi.org/10.3390/curroncol30070470
Journal volume & issue
Vol. 30, no. 7
pp. 6374 – 6396

Abstract

Read online

Uveal melanoma represents the most prevalent form of primary malignant intraocular tumor in adults. Historically, enucleation was considered the gold-standard approach in the treatment of uveal melanoma. Currently, radiotherapy is the most commonly used therapy, aiming at a better quality of life. However, radiotherapy can result in several ocular complications, some of which may be vision-threatening. Radiation-induced dry eye, scleral necrosis, cataract, rubeosis iridis, neovascular glaucoma, radiation retinopathy, maculopathy, and optic neuropathy are the most common complications. This article aims to summarize the current literature regarding the ocular complications after radiotherapy, as well as their clinical features, risk factors, and management strategies. A thorough understanding of these issues is crucial for ophthalmologists and oncologists to provide optimal patient care, improve visual outcomes, and minimize long-term complications.

Keywords